On Demand Pharmaceuticals and Wavelength Pharmaceuticals Awarded BIRD Foundation Grant
Investment
Tikun olam-Cannbit continues to expand its footprint in the pharmaceutical arena
Partners
Wavelength Pharmaceuticals Further Strengthens Its Global Supply Chain with Acquisition of Vanamali Organics
Wavelength Pharmaceuticals Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19 Patients
Wavelength Ups API Production for Essential Respiratory Meds
CustomersExpand
Wavelength Pharmaceuticals Names Iftach Seri as Chief Executive Officer and Tami Cohen as Chief Financial Officer
Perrigo completes sale of Israeli unit Chemagis for $110m
Acquisition
SK Capital buys Perrigo's Israel unit Chemagis for $110m
AcquisitionInvestment